Moderna Announces Pricing Of Upsized $2.6B 0.00% Convertible Senior Notes Due 2032; Initial Conversion Price $210.58/Share, A 47.5% Premium, With Capped Call Cap At 175% Premium
Share
Why It Matters
Moderna is borrowing $2.6 billion by selling special bonds that can turn into stock later at $210.58 per share—higher than today's price. This is a common way big companies raise money when they believe their stock will be worth more in the future.
This read is generated by AI from raw market data and is for education only. It is not financial advice, not a signal, and not a recommendation to buy or sell.
Tickers in Play
Last session drawn · prints held ~15 minutes · licensed exchange data
Source: Benzinga · Read the original report at the publisher. Headline and figures shown for context; data may be delayed.
Disclosure: Educational and informational purposes only — not financial advice. We educate, not advise. Market data may be delayed up to 15 minutes unless marked real-time. Past performance is not indicative of future results.